Full-Spectrum Extract
A cannabis extract containing the full range of cannabinoids, terpenes, flavonoids, and other phytochemicals present in the original plant material.
In Depth
Full-spectrum extracts are contrasted with broad-spectrum (THC removed) and isolate (single compound) products. Proponents argue full-spectrum products produce superior therapeutic effects via the entourage effect. From a regulatory standpoint, full-spectrum extracts containing >0.3% THC are classified as marijuana under US federal law. Standardization and batch-to-batch consistency remain challenges for research and clinical use.
Related Terms
More in Pharmacology
Endocannabinoid System (ECS)
A lipid-based retrograde neurotransmitter system comprising endogenous cannabinoids (endocannabinoids), their receptors (CB1, CB2), and metabolic enzymes.
CB1 Receptor
Cannabinoid receptor type 1. A G protein-coupled receptor (GPCR) primarily expressed in the central nervous system. The primary target of THC's psychoactive effects.
CB2 Receptor
Cannabinoid receptor type 2. A GPCR primarily expressed in immune tissues and peripheral organs. Less abundant in the CNS than CB1.
Anandamide (AEA)
N-arachidonoylethanolamine. The first endocannabinoid identified. A partial agonist at CB1 and CB2 receptors, named from the Sanskrit word "ananda" meaning bliss.
2-Arachidonoylglycerol (2-AG)
The most abundant endocannabinoid in the brain. A full agonist at both CB1 and CB2 receptors.